Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Alerting the body to tissue injury: The role of alarmins and DAMPs in cutaneous wound healing.

Wilgus TA.

Curr Pathobiol Rep. 2018 Mar;6(1):55-60. doi: 10.1007/s40139-018-0162-1. Epub 2018 Jan 20.

PMID:
29862143
2.

New Mechanisms of ECM Production during Wound Healing: A Role for Parathyroid Hormone 2 Receptor Signaling.

Wilgus TA.

J Invest Dermatol. 2017 Aug;137(8):1617-1619. doi: 10.1016/j.jid.2017.05.001. Review.

3.

Inflammatory responses, matrix remodeling, and re-epithelialization after fractional CO2 laser treatment of scars.

DeBruler DM, Blackstone BN, Baumann ME, McFarland KL, Wulff BC, Wilgus TA, Bailey JK, Supp DM, Powell HM.

Lasers Surg Med. 2017 Sep;49(7):675-685. doi: 10.1002/lsm.22666. Epub 2017 May 10.

PMID:
28489283
4.

Deterministic transfection drives efficient nonviral reprogramming and uncovers reprogramming barriers.

Gallego-Perez D, Otero JJ, Czeisler C, Ma J, Ortiz C, Gygli P, Catacutan FP, Gokozan HN, Cowgill A, Sherwood T, Ghatak S, Malkoc V, Zhao X, Liao WC, Gnyawali S, Wang X, Adler AF, Leong K, Wulff B, Wilgus TA, Askwith C, Khanna S, Rink C, Sen CK, Lee LJ.

Nanomedicine. 2016 Feb;12(2):399-409. doi: 10.1016/j.nano.2015.11.015. Epub 2015 Dec 19.

5.

Vascular Endothelial Growth Factor and Angiogenesis in the Regulation of Cutaneous Wound Repair.

Johnson KE, Wilgus TA.

Adv Wound Care (New Rochelle). 2014 Oct 1;3(10):647-661. Review.

6.

The Importance of Mast Cells in Dermal Scarring.

Wilgus TA, Wulff BC.

Adv Wound Care (New Rochelle). 2014 Apr 1;3(4):356-365. Review.

7.

Neutrophils and Wound Repair: Positive Actions and Negative Reactions.

Wilgus TA, Roy S, McDaniel JC.

Adv Wound Care (New Rochelle). 2013 Sep;2(7):379-388. Review.

8.

Blockade of mast cell activation reduces cutaneous scar formation.

Chen L, Schrementi ME, Ranzer MJ, Wilgus TA, DiPietro LA.

PLoS One. 2014 Jan 22;9(1):e85226. doi: 10.1371/journal.pone.0085226. eCollection 2014.

9.

Examining the role of mast cells in fetal wound healing using cultured cells in vitro.

Wulff BC, Wilgus TA.

Methods Mol Biol. 2013;1037:495-506. doi: 10.1007/978-1-62703-505-7_29.

PMID:
24029955
10.

Ultraviolet light exposure stimulates HMGB1 release by keratinocytes.

Johnson KE, Wulff BC, Oberyszyn TM, Wilgus TA.

Arch Dermatol Res. 2013 Nov;305(9):805-15. doi: 10.1007/s00403-013-1401-2. Epub 2013 Aug 13.

11.

Mast cell activity in the healing wound: more than meets the eye?

Wulff BC, Wilgus TA.

Exp Dermatol. 2013 Aug;22(8):507-10. doi: 10.1111/exd.12169. Epub 2013 Jun 27. Review.

12.

Neutrophil activity in chronic venous leg ulcers--a target for therapy?

McDaniel JC, Roy S, Wilgus TA.

Wound Repair Regen. 2013 May-Jun;21(3):339-51. doi: 10.1111/wrr.12036. Epub 2013 Mar 28. Review.

13.

The alarmin HMGB-1 influences healing outcomes in fetal skin wounds.

Dardenne AD, Wulff BC, Wilgus TA.

Wound Repair Regen. 2013 Mar-Apr;21(2):282-91. doi: 10.1111/wrr.12028. Epub 2013 Feb 25.

14.

Growth Factor-Extracellular Matrix Interactions Regulate Wound Repair.

Wilgus TA.

Adv Wound Care (New Rochelle). 2012 Dec;1(6):249-254. Review.

15.

Novel differences in the expression of inflammation-associated genes between mid- and late-gestational dermal fibroblasts.

Wulff BC, Yu L, Parent AE, Wilgus TA.

Wound Repair Regen. 2013 Jan-Feb;21(1):103-12. doi: 10.1111/j.1524-475X.2012.00860.x. Epub 2012 Nov 5.

16.

Multiple roles for VEGF in non-melanoma skin cancer: angiogenesis and beyond.

Johnson KE, Wilgus TA.

J Skin Cancer. 2012;2012:483439. doi: 10.1155/2012/483439. Epub 2012 Oct 17.

17.

Hyperoxemic reperfusion after prolonged cardiac arrest in a rat cardiopulmonary bypass resuscitation model.

Yeh ST, Aune SE, Wilgus TA, Parent AE, Angelos MG.

Resuscitation. 2013 Jan;84(1):114-20. doi: 10.1016/j.resuscitation.2012.08.323. Epub 2012 Sep 14.

18.

Complex roles for VEGF in dermal wound healing.

Wilgus TA, DiPietro LA.

J Invest Dermatol. 2012 Feb;132(2):493-4. doi: 10.1038/jid.2011.343. Epub 2011 Nov 10. No abstract available.

19.

Mast cells contribute to scar formation during fetal wound healing.

Wulff BC, Parent AE, Meleski MA, DiPietro LA, Schrementi ME, Wilgus TA.

J Invest Dermatol. 2012 Feb;132(2):458-65. doi: 10.1038/jid.2011.324. Epub 2011 Oct 13.

20.

Immune cells in the healing skin wound: influential players at each stage of repair.

Wilgus TA.

Pharmacol Res. 2008 Aug;58(2):112-6. doi: 10.1016/j.phrs.2008.07.009. Epub 2008 Aug 3. Review.

PMID:
18723091
21.

Regulation of scar formation by vascular endothelial growth factor.

Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA.

Lab Invest. 2008 Jun;88(6):579-90. doi: 10.1038/labinvest.2008.36. Epub 2008 Apr 21.

22.

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3.

Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, Appukuttan B, Gibbs D, Yang Z, Karikó K, Ambati BK, Wilgus TA, DiPietro LA, Sakurai E, Zhang K, Smith JR, Taylor EW, Ambati J.

Nature. 2008 Apr 3;452(7187):591-7. doi: 10.1038/nature06765. Epub 2008 Mar 26.

23.

Regenerative healing in fetal skin: a review of the literature.

Wilgus TA.

Ostomy Wound Manage. 2007 Jun;53(6):16-31; quiz 32-3. Review.

PMID:
17586870
24.

Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development.

Tober KL, Wilgus TA, Kusewitt DF, Thomas-Ahner JM, Maruyama T, Oberyszyn TM.

J Invest Dermatol. 2006 Jan;126(1):205-11.

25.

Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes.

Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA.

Am J Pathol. 2005 Nov;167(5):1257-66.

26.

Hydrogen peroxide disrupts scarless fetal wound repair.

Wilgus TA, Bergdall VK, Dipietro LA, Oberyszyn TM.

Wound Repair Regen. 2005 Sep-Oct;13(5):513-9.

PMID:
16176460
27.

The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing.

Wilgus TA, Bergdall VK, Tober KL, Hill KJ, Mitra S, Flavahan NA, Oberyszyn TM.

Am J Pathol. 2004 Sep;165(3):753-61.

28.

Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors.

Wilgus TA, Breza TS Jr, Tober KL, Oberyszyn TM.

J Invest Dermatol. 2004 Jun;122(6):1488-94.

29.

Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.

Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM.

Mol Carcinog. 2003 Oct;38(2):49-58.

PMID:
14502644
30.

Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.

Wilgus TA, Koki AT, Zweifel BS, Rubal PA, Oberyszyn TM.

Mol Carcinog. 2003 Sep;38(1):33-9.

PMID:
12949841
31.

Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor.

Wilgus TA, Parrett ML, Ross MS, Tober KL, Robertson FM, Oberyszyn TM.

Adv Exp Med Biol. 2002;507:85-92.

PMID:
12664569
32.

Reduction of scar formation in full-thickness wounds with topical celecoxib treatment.

Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM.

Wound Repair Regen. 2003 Jan-Feb;11(1):25-34.

PMID:
12581424
33.

Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide.

Oberyszyn TM, Robertson FM, Tober KL, Ross MS, Parrett ML, Wilgus TA, Iyer S, Woo J, Buelow R.

Photochem Photobiol. 2001 Feb;73(2):184-90.

PMID:
11272733
34.

Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.

Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM.

Prostaglandins Other Lipid Mediat. 2000 Oct;62(4):367-84.

PMID:
11060900

Supplemental Content

Loading ...
Support Center